Chemical Structure : NCP07
Catalog No.: PC-28640Not For Human Use, Lab Use Only.
NCP07 is a potent, ERα coactivator-binding site (CBS) targeting PROTAC degrader of ERα, degrades ERα and its mutants in breast cancer cells, significantly degrades ERα (DC50<10 uM) in MCF-7, T47D and ESR1 mutant breast cancer cells (MCF-7EGFR, MCF-7D538G and MCF-7Y537S).
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
NCP07 is a potent, ERα coactivator-binding site (CBS) targeting PROTAC degrader of ERα, degrades ERα and its mutants in breast cancer cells, significantly degrades ERα (DC50<10 uM) in MCF-7, T47D and ESR1 mutant breast cancer cells (MCF-7EGFR, MCF-7D538G and MCF-7Y537S).
NCP07 exhibits significant anti-proliferation activities in MCF-7 breast cancer cells with IC50 of 0.25 uM.
NCP07 inhibited proliferation (IC5=0.13-1.22 uM) in both wild-type and ESR1-mutated cell lines.
NCP07 can not only specifically bind to CBS followed by inducing the formation of ERα-NCP07-VHL ternary complex, but also induce apoptosis and cell cycle arrest in drug-resistant cells.
| M.Wt | 1121.32 | |
| Formula | C58H72N8O13S | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
1. Jinsen Liang, et al. Eur J Med Chem. 2026 Nov 5:317:119113.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright